Inspira Technologies Oxy B.H.N. Ltd. (IINN)
After hours:
| Previous close | 1.9500 |
| Open | 1.9200 |
| Bid | 1.8600 x 100 |
| Ask | 1.9500 x 100 |
| Day's range | 1.8350 - 1.9700 |
| 52-week range | 0.7610 - 2.4900 |
| Volume | |
| Avg. volume | 202,023 |
| Market cap | 33.013M |
| Beta (5Y monthly) | 2.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.
Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira"), a breakthrough medical technology company, today announced that is has received the first purchase order from Glo-Med Networks, Inc. ("Glo-Med") for its INSPIRA™ ART100 systems, with the five product units expected to be shipped in the fourth quarter of 2024. The purchase order also provides for the potential purchase of an additional 20 systems, the timing of which is subject to further agreement between I
- PR Newswire
Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector
Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, is proud to announce plans to exhibit the INSPIRA™ ART100 System, recently cleared by the U.S. Food and Drug Administration ("FDA"), at the Extracorporeal Life Support Organization (ELSO) conference in Detroit, Michigan between September 29 to October 1, 2024.
- PR Newswire
Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN, IINNW) (the "Company" or "Inspira") a breakthrough medical technology company, announced today that Company President, Director, and co-founder, Mr. Joe Hayon, will discuss the Company's business targets, distribution agreements and next steps in a conference call to be held at 9:00am Eastern Time on Thursday, June 20, 2024. This follows the significant milestone of receiving FDA clearance for the INSPIRA™ ART100 system, as announced on May 28
